Results 141 to 150 of about 41,531 (223)

A Frameshift Mutation in the Methyltransferase <i>rlmN</i> Is Associated with Increased Linezolid Resistance in <i>Mycobacterium tuberculosis</i>. [PDF]

Comput Struct Biotechnol J
Reimer BM, Green AG.
europepmc   +1 more source

Performance of EUCAST disc diffusion and supplementary methods to detect reduced susceptibility to linezolid in enterococci- the NordicAST LRE-study. [PDF]

J Antimicrob Chemother
Haldorsen BC, Augustinussen MH, Matuschek E, Småbrekke L, Skjold F, Hegstad J, Holzknecht BJ, Helgason KO, Ilmavirta H, Kahlmeter G, Sundsfjord A, Hegstad K, NordicAST 2023 LRE-TRE Study Group .   +12 more
europepmc   +1 more source

Prolonged linezolid therapy induces progressive mitochondrial dysfunction in human peripheral blood mononuclear cells. [PDF]

J Transl Med
Martínez-Guitián M, Cajade-Pascual F, Castro-Fernández DC, Cuartero-Martínez A, Nogueiras R, Fernández-Castro I, Molinos-Castro S, Ortea I, Zarra-Ferro I, González-Barcia M, Fernández-Ferreiro A, Mondelo-García C.   +11 more
europepmc   +1 more source

A Case of Transmission of Bedaquiline- and Linezolid-Resistant Tuberculosis. [PDF]

Int J Mol Sci
Ushtanit A, Peretokina I, Krylova L, Safonova S, Filippov A, Zimenkov D.   +5 more
europepmc   +1 more source

Low prevalence of Cfr-mediated linezolid resistance among methicillin-resistant Staphylococcus aureus in a Spanish hospital: case report on linezolid resistance acquired during linezolid therapy

Linezolid is an effective antimicrobial agent to treat methicillin-resistant Staphylococcus aureus (MRSA). Resistance to linezolid due to the cfr gene is described worldwide. The present study aimed to analyze the prevalence of the cfr-mediated linezolid
Sierra, Josep M., Martin, Rogelio, Tubau, Fe, Gasch, Oriol, Camoez, Mariana, Domínguez Luzón, Ma. Ángeles (María Ángeles), Pujol Rojo, Miquel   +6 more
core  

Development and Application of a Desirability of Outcome Ranking (DOOR) Endpoint for Acute Bacterial Skin and Skin Structure Infections. [PDF]

Open Forum Infect Dis
Howard-Anderson J, Hamasaki T, Ge L, Collyar D, Cosgrove SE, Doernberg SB, Geres H, Gopinath R, Holland TL, King HA, Nambiar S, Rubin D, Chambers HF, Fowler VG, Evans SR, Boucher HW.   +15 more
europepmc   +1 more source

Growth Differentiation Factor-15 Could Predict Decreased Hemoglobin in Tuberculosis Treated With Linezolid-Containing Regimen. [PDF]

Clin Respir J
Oehadian A, Santoso P, Prihatni D, Kartikasari A, Parwati I, Handayani D, Handoyo T, Sutandiyo N, Alisjahbana B, Menzies D, Ruslami R.   +10 more
europepmc   +1 more source

Breaking barriers in extensively drug-resistant TB: pretomanid-centred long regimen achieves cure in a bedaquiline-resistant strain. [PDF]

IJTLD Open
Schiuma M, Piubello A, Saluzzo F, Cattaneo D, Salari F, Covizzi A, Rizzo A, Fama F, Ciubotariu C, Lombardi A, Antinori S, Riva A, Cirillo DM, Gori A, Torre A.   +14 more
europepmc   +1 more source

ePosters Virtual

European Journal of Neurology, Volume 33, Issue S1, June 2026.
wiley   +1 more source

Efficacy and tolerability of linezolid as an adjunctive treatment for nontuberculous mycobacterial infections in patients with adult-onset immunodeficiency syndrome: a prospective cohort study. [PDF]

Ann Med
Phoompoung P, Chavapradit N, Foongladda S, Chirapapaisan N, Suputtamongkol Y, Angkasekwinai N.   +5 more
europepmc   +1 more source